seselin has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, L; Kong, L; Shen, Y; Song, P; Sun, Y; Wu, X; Xu, L; Xu, Q | 1 |
| Barthwal, MK; Dikshit, M; Jain, M; Khanna, V; Kumar, S; Misra, A; Prakash, P; Raj, K; Siddiqui, HH; Singh, V; Surin, WR | 1 |
2 other study(ies) available for seselin and Disease Models, Animal
| Article | Year |
|---|---|
Seselin ameliorates inflammation via targeting Jak2 to suppress the proinflammatory phenotype of macrophages.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Coumarins; Disease Models, Animal; Female; Inflammation; Janus Kinase 2; Macrophages; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Phenotype; Receptors, Interferon; Sepsis; STAT1 Transcription Factor | 2019 |
Antithrombotic activity of a newly synthesized coumarin derivative 3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-N-{2-[3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-propionylamino]-ethyl}-propionamide.
Topics: Animals; Bleeding Time; Chromans; Coumarins; Cricetinae; Disease Models, Animal; Dyslipidemias; Fibrinolytic Agents; Male; Mice; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Rats; Rats, Sprague-Dawley; Thrombosis | 2013 |